Skip to content
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the […]
BIO Board member and head of BioUtah testify at House field hearing Read More »
The Federal Trade Commission (FTC) released an interim report on July 9 criticizing the negative impact pharmacy benefit managers (PBMs) have on prescription drug
FTC releases interim report criticizing PBMs Read More »
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
Microbial ecology and its potential applications are gaining prominence in biotechnology and healthcare. Cambridge-based Concerto Biosciences is helping drive advances in this area with
NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes Read More »
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
In recognition of significant advancements in biotechnology’s impact on our food supply, the Biotechnology Innovation Organization (BIO) recently recognized industry leaders who helped drive
BIO honors innovators with 2024 Leadership in Agri-Biotechnology Awards Read More »
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate
NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets Read More »
The Centers for Disease Prevention and Control (CDC) recently issued new recommendations to enhance preparedness for the upcoming respiratory virus season. These guidelines focus
CDC issues new guidelines to prepare for respiratory virus season Read More »
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
As 2024 Pride Month concludes, the biotech industry reflects on the critical importance of LGBTQ+ representation and the ongoing efforts to foster inclusivity. The
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps Read More »
